HALOPERIDOL Side Effects

7019955-4 | Blunted Affect, Psychomotor Retardation, Salivary Hypersecretion
on Sep 20, 2010 Male patient from UNITED STATES , 26 years of age, was diagnosed with thinking abnormal, paranoia and was treated with Haloperidol (View Usage). Patient experienced the following unwanted or unexpected effects: blunted affect, psychomotor retardation, salivary hypersecretion. Haloperidol dosage: . During the same period patient was treated with QUETIAPINE (View Quetiapine Review and Quetiapine Label ).

7019660-4 | Liver Function Test Abnormal
Patient was taking Haloperidol (View Usage). Patient had the following side effects: liver function test abnormal on Sep 28, 2010 from UNITED STATES Additional patient health information: Male patient , 25 years of age, weighting 200.0 lb, . Haloperidol dosage: 20 Mg Daily Po.

7012420-X | Psychotic Disorder, Treatment Noncompliance
Adverse event was reported on Sep 17, 2010 by a Female patient taking Haloperidol (View Usage) (Dosage: ) was diagnosed with psychotic disorder (What is psychotic disorder?) and. Location: IRELAND , weighting 172.0 lb, After Haloperidol was administered, patient had the following side effects: psychotic disorder (What is psychotic disorder?), treatment noncompliance. During the same period patient was treated with ARIPIPRAZOLE (View Aripiprazole Review and Aripiprazole Label ), GENOTROPIN (View Genotropin Review and Genotropin Label ). Patient was hospitalized.

7012083-3 | Dehydration, Sedation
on Sep 14, 2010 Female patient from UNITED KINGDOM , 17 years of age, was diagnosed with mania and was treated with Haloperidol (View Usage). Patient experienced the following unwanted or unexpected effects: dehydration, sedation. Haloperidol dosage: Upto 20 Mg.


7011035-7 | Aggression, Catatonia, Confusional State, Mental Status Changes, Sleep Disorder, Tremor
on Sep 22, 2010 Male patient from UNITED STATES , 57 years of age, was diagnosed with aggression, affective disorder and was treated with Haloperidol (View Usage). Patient had the following side effects: aggression, catatonia, confusional state, mental status changes, sleep disorder (What is sleep disorder?), tremor. Haloperidol dosage: 10 Mg State Im. During the same period patient was treated with OXCARBAZEPINE (300 Mg Bid Po) (View Oxcarbazepine Review and Oxcarbazepine Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), ZIPRASIDONE HCL (View Ziprasidone Hcl Review and Ziprasidone Hcl Label ), LITHIUM CARBONATE (View Lithium Carbonate Review and Lithium Carbonate Label ), QUETIAPINE (View Quetiapine Review and Quetiapine Label ), CLONAZEPAM (View Clonazepam Review and Clonazepam Label ), METFORMIN (View Metformin Review and Metformin Label ), GLIPIZIDE (View Glipizide Review and Glipizide Label ). Patient was hospitalized.

7005175-6 | Dystonia, Protrusion Tongue
Patient was taking Haloperidol (View Usage). After Haloperidol was administered, patient had the following side effects: dystonia (What is dystonia?), protrusion tongue on Sep 20, 2010 from UNITED STATES Additional patient health information: Male patient , 56 years of age, weighting 171.0 lb, was diagnosed with blood ethanol and. Haloperidol dosage: 5 Mg Bid Po. Patient was hospitalized.

7005071-4 | Delusion, Hallucination, Torticollis
Adverse event was reported on Sep 09, 2010 by a Male patient taking Haloperidol (View Usage) (Dosage: ) was diagnosed with delusion, hallucination and. Location: JAPAN , 52 years of age, Patient experienced the following unwanted or unexpected effects: delusion, hallucination, torticollis. During the same period patient was treated with CHLORPROMAZINE (View Chlorpromazine Review and Chlorpromazine Label ). Patient was hospitalized.

6994664-6 | Dystonia
on Sep 15, 2010 Male patient from UNITED STATES , 22 years of age, weighting 201.1 lb, was diagnosed with schizoaffective disorder and was treated with Haloperidol (View Usage). Patient had the following side effects: dystonia (What is dystonia?). Haloperidol dosage: 5 Mg Other Po.

6994404-0 | Torticollis
on Sep 09, 2010 Male patient from JAPAN , 50 years of age, was treated with Haloperidol (View Usage). After Haloperidol was administered, patient had the following side effects: torticollis. Haloperidol dosage: . During the same period patient was treated with BIPERIDEN HYDROCHLORIDE TAB (View Biperiden Hydrochloride Tab Review and Biperiden Hydrochloride Tab Label ), LEVOMEPROMAZINE (View Levomepromazine Review and Levomepromazine Label ). Patient was hospitalized.

6994403-9 | Dystonia
Patient was taking Haloperidol (View Usage). Patient experienced the following unwanted or unexpected effects: dystonia (What is dystonia?) on Sep 09, 2010 from JAPAN Additional patient health information: Female patient , 38 years of age, . Haloperidol dosage: . During the same period patient was treated with CARBAMAZEPINE (View Carbamazepine Review and Carbamazepine Label ), BIPERIDEN HYDROCHLORIDE TAB (View Biperiden Hydrochloride Tab Review and Biperiden Hydrochloride Tab Label ). Patient was hospitalized.

6994402-7 | Torticollis
Adverse event was reported on Sep 09, 2010 by a Female patient taking Haloperidol (View Usage) (Dosage: ) was diagnosed with schizophrenia and. Location: JAPAN , 58 years of age, Patient had the following side effects: torticollis. During the same period patient was treated with FLUNITRAZEPAM (View Flunitrazepam Review and Flunitrazepam Label ).

6979462-1 | Aphasia, Body Temperature Decreased, Drooling, Somnolence, Vomiting
on Sep 10, 2010 Female patient from UNITED STATES , 49 years of age, was diagnosed with schizoaffective disorder and was treated with Haloperidol (View Usage). After Haloperidol was administered, patient had the following side effects: aphasia (What is aphasia?), body temperature decreased, drooling, somnolence, vomiting. Haloperidol dosage: 5mg One Time Im. During the same period patient was treated with LORAZEPAM (2mg One Time Im) (View Lorazepam Review and Lorazepam Label ), ZYDIS 20MG LILLY (20mg One Time Po) (View Zydis 20mg Lilly Review and Zydis 20mg Lilly Label ). Patient was hospitalized.

6967058-7 | Dyskinesia, Psychotic Disorder
on Aug 24, 2010 Male patient from NEW ZEALAND , 50 years of age, was diagnosed with schizoaffective disorder and was treated with Haloperidol (View Usage). Patient experienced the following unwanted or unexpected effects: dyskinesia, psychotic disorder (What is psychotic disorder?). Haloperidol dosage: . During the same period patient was treated with LITHIUM CARBONATE (View Lithium Carbonate Review and Lithium Carbonate Label ).

6939983-4 | Blood Creatinine Increased, Infection, Labile Blood Pressure, Neuroleptic Malignant Syndrome, Pyrexia
Patient was taking Haloperidol (View Usage). Patient had the following side effects: blood creatinine increased, infection (What is infection?), labile blood pressure, neuroleptic malignant syndrome, pyrexia on Aug 23, 2010 from UNITED KINGDOM Additional patient health information: Female patient , 45 years of age, was diagnosed with psychotic disorder (What is psychotic disorder?), agitation and. Haloperidol dosage: . During the same period patient was treated with OLANZAPINE (View Olanzapine Review and Olanzapine Label ), CITALOPRAM HYDROBROMIDE (View Citalopram Hydrobromide Review and Citalopram Hydrobromide Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), QUETIAPINE (View Quetiapine Review and Quetiapine Label ). Patient was hospitalized.

6927725-8 | Dystonia
Adverse event was reported on Aug 16, 2010 by a Male patient taking Haloperidol (View Usage) (Dosage: 2 Mg Bid Po) was diagnosed with agitation and. Location: UNITED STATES , 30 years of age, weighting 110.0 lb, After Haloperidol was administered, patient had the following side effects: dystonia (What is dystonia?). Patient was hospitalized.

6924158-5 | Dystonia, Muscle Spasms
on Aug 12, 2010 Female patient from UNITED STATES , 21 years of age, was treated with Haloperidol (View Usage). Patient experienced the following unwanted or unexpected effects: dystonia (What is dystonia?), muscle spasms. Haloperidol dosage: .

6923270-4 | Akathisia, Apraxia, Cardiac Failure, Hemisensory Neglect, Neuroleptic Malignant Syndrome, Pulmonary Embolism
on Aug 10, 2010 Female patient from GERMANY , 76 years of age, weighting 99.21 lb, was diagnosed with psychotic disorder (What is psychotic disorder?) and was treated with Haloperidol (View Usage). Patient had the following side effects: akathisia, apraxia, cardiac failure, hemisensory neglect, neuroleptic malignant syndrome, pulmonary embolism (What is pulmonary embolism?). Haloperidol dosage: . During the same period patient was treated with EUNERPAN (View Eunerpan Review and Eunerpan Label ), MELPERON (View Melperon Review and Melperon Label ), MELNEURIN (1 Daily Dose On Discharge Day) (View Melneurin Review and Melneurin Label ), DIAZEPAM (View Diazepam Review and Diazepam Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), XANAX (View Xanax Review and Xanax Label ). Patient was hospitalized.

6914881-0 | Depressed Level Of Consciousness, Hypotension, Somnolence
Patient was taking Haloperidol (View Usage). After Haloperidol was administered, patient had the following side effects: depressed level of consciousness, hypotension, somnolence on Aug 04, 2010 from UNITED STATES Additional patient health information: Female patient , 54 years of age, . Haloperidol dosage: . Patient was hospitalized.

6914708-7 | Convulsion, Hallucination, Neuroleptic Malignant Syndrome
Adverse event was reported on Aug 04, 2010 by a Male patient taking Haloperidol (View Usage) (Dosage: 0.5 Mg Bid Po) was diagnosed with agitation and. Location: UNITED STATES , 62 years of age, weighting 149.9 lb, Patient experienced the following unwanted or unexpected effects: convulsion, hallucination, neuroleptic malignant syndrome. Patient was hospitalized.

6913688-8 | Catatonia, Cogwheel Rigidity, Parkinsonian Gait
on Aug 05, 2010 Female patient from AUSTRALIA , 34 years of age, was diagnosed with mania and was treated with Haloperidol (View Usage). Patient had the following side effects: catatonia, cogwheel rigidity, parkinsonian gait. Haloperidol dosage: . During the same period patient was treated with LITHIUM CORBONATE (View Lithium Corbonate Review and Lithium Corbonate Label ).

6910129-1 | Bradykinesia, Catatonia, Parkinsonian Gait, Salivary Hypersecretion, Seborrhoea
on Jul 28, 2010 Female patient from AUSTRALIA , 22 years of age, was diagnosed with schizophrenia and was treated with Haloperidol (View Usage). After Haloperidol was administered, patient had the following side effects: bradykinesia, catatonia, parkinsonian gait, salivary hypersecretion, seborrhoea. Haloperidol dosage: . During the same period patient was treated with CHLORPROMAZINE (View Chlorpromazine Review and Chlorpromazine Label ), PROCYCLIDINE HYDROCHLORIDE 2MG TAB (View Procyclidine Hydrochloride 2mg Tab Review and Procyclidine Hydrochloride 2mg Tab Label ).

6910128-X | Bradykinesia, Catatonia, Cogwheel Rigidity, Parkinsonian Gait, Tremor
Patient was taking Haloperidol (View Usage). Patient experienced the following unwanted or unexpected effects: bradykinesia, catatonia, cogwheel rigidity, parkinsonian gait, tremor on Jul 28, 2010 from AUSTRALIA Additional patient health information: Male patient , 49 years of age, was diagnosed with amnestic disorder, schizophrenia and. Haloperidol dosage: . During the same period patient was treated with THIORIDAZINE HCL (View Thioridazine Hcl Review and Thioridazine Hcl Label ).

6909127-3 | Bradykinesia, Catatonia, Cogwheel Rigidity, Parkinsonian Gait, Salivary Hypersecretion
Adverse event was reported on Jul 28, 2010 by a Male patient taking Haloperidol (View Usage) (Dosage: ) was diagnosed with epilepsy (What is epilepsy?), dementia (What is dementia?) and. Location: AUSTRALIA , 47 years of age, Patient had the following side effects: bradykinesia, catatonia, cogwheel rigidity, parkinsonian gait, salivary hypersecretion. During the same period patient was treated with CARBAMAZEPINE (View Carbamazepine Review and Carbamazepine Label ).

6909126-1 | Catatonia, Cogwheel Rigidity, Parkinsonian Gait, Tremor
on Jul 28, 2010 Female patient from AUSTRALIA , 73 years of age, was diagnosed with bipolar disorder (What is bipolar disorder?) and was treated with Haloperidol (View Usage). After Haloperidol was administered, patient had the following side effects: catatonia, cogwheel rigidity, parkinsonian gait, tremor. Haloperidol dosage: . During the same period patient was treated with CARBAMAZEPINE (View Carbamazepine Review and Carbamazepine Label ), TRIFLUOPERAZINE (View Trifluoperazine Review and Trifluoperazine Label ).

6909118-2 | Bradykinesia, Catatonia, Cogwheel Rigidity, Parkinsonian Gait, Salivary Hypersecretion, Seborrhoea, Tremor
on Jul 28, 2010 Female patient from AUSTRALIA , 32 years of age, was diagnosed with mania and was treated with Haloperidol (View Usage). Patient experienced the following unwanted or unexpected effects: bradykinesia, catatonia, cogwheel rigidity, parkinsonian gait, salivary hypersecretion, seborrhoea, tremor. Haloperidol dosage: . During the same period patient was treated with LITHIUM CARBONATE (View Lithium Carbonate Review and Lithium Carbonate Label ), CHLORPROMAZINE (View Chlorpromazine Review and Chlorpromazine Label ).

6909117-0 | Catatonia, Cogwheel Rigidity, Parkinsonian Gait
Patient was taking Haloperidol (View Usage). Patient had the following side effects: catatonia, cogwheel rigidity, parkinsonian gait on Jul 28, 2010 from AUSTRALIA Additional patient health information: Female patient , 34 years of age, was diagnosed with mania and. Haloperidol dosage: . During the same period patient was treated with LITHIUM CARBONATE (View Lithium Carbonate Review and Lithium Carbonate Label ).

6909116-9 | Catatonia, Cogwheel Rigidity, Parkinsonian Gait
Adverse event was reported on Jul 28, 2010 by a Male patient taking Haloperidol (View Usage) (Dosage: ) was diagnosed with mania and. Location: AUSTRALIA , 59 years of age, After Haloperidol was administered, patient had the following side effects: catatonia, cogwheel rigidity, parkinsonian gait. During the same period patient was treated with LITHIUM CARBONATE (View Lithium Carbonate Review and Lithium Carbonate Label ), CHLORPROMAZINE (View Chlorpromazine Review and Chlorpromazine Label ).

6909115-7 | Catatonia, Cogwheel Rigidity, Seborrhoea
on Jul 28, 2010 Male patient from AUSTRALIA , 18 years of age, was diagnosed with mania and was treated with Haloperidol (View Usage). Patient experienced the following unwanted or unexpected effects: catatonia, cogwheel rigidity, seborrhoea. Haloperidol dosage: . During the same period patient was treated with LITHIUM CARBONATE (View Lithium Carbonate Review and Lithium Carbonate Label ).

6909114-5 | Bradykinesia, Catatonia, Cogwheel Rigidity, Parkinsonian Gait
on Jul 28, 2010 Female patient from AUSTRALIA , 25 years of age, was diagnosed with mania and was treated with Haloperidol (View Usage). Patient had the following side effects: bradykinesia, catatonia, cogwheel rigidity, parkinsonian gait. Haloperidol dosage: . During the same period patient was treated with LITHIUM CARBONATE (View Lithium Carbonate Review and Lithium Carbonate Label ), BENZTROPINE MESYLATE (View Benztropine Mesylate Review and Benztropine Mesylate Label ), CHLORPROMAZINE (View Chlorpromazine Review and Chlorpromazine Label ).

6871847-7 | Confusional State, Hallucination, Sedation
Patient was taking Haloperidol (View Usage). After Haloperidol was administered, patient had the following side effects: confusional state, hallucination, sedation on Jul 15, 2010 from UNITED KINGDOM Additional patient health information: Female patient , 45 years of age, was diagnosed with psychotic disorder (What is psychotic disorder?), insomnia, anxiety (What is anxiety?), pain (What is pain?), affective disorder and. Haloperidol dosage: . During the same period patient was treated with CAFFEINE (View Caffeine Review and Caffeine Label ), DIAZEPAM (View Diazepam Review and Diazepam Label ), DIHYDROCODEINE BITARTRATE INJ (View Dihydrocodeine Bitartrate Inj Review and Dihydrocodeine Bitartrate Inj Label ), VALPROATE SODIUM (View Valproate Sodium Review and Valproate Sodium Label ), ZOLPIDEM (View Zolpidem Review and Zolpidem Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), ASPIRIN (View Aspirin Review and Aspirin Label ).

6871249-3 | Arrhythmia, Hypertonia, Irritability
Adverse event was reported on Jul 12, 2010 by a Female patient taking Haloperidol (View Usage) (Dosage: ) . Location: ISRAEL , weighting 8.51 lb, Patient experienced the following unwanted or unexpected effects: arrhythmia (What is arrhythmia?), hypertonia, irritability. During the same period patient was treated with PENFLURIDOL (View Penfluridol Review and Penfluridol Label ), DIAZEPAM (View Diazepam Review and Diazepam Label ).

6871248-1 | Feeling Jittery
on Jul 12, 2010 Female patient from ISRAEL , weighting 6.06 lb, was treated with Haloperidol (View Usage). Patient had the following side effects: feeling jittery. Haloperidol dosage: . During the same period patient was treated with PENFLURIDOL (View Penfluridol Review and Penfluridol Label ), LITHIUM (View Lithium Review and Lithium Label ).

6870883-4 | Emphysema, Respiratory Disorder
on Jul 12, 2010 Female patient from ISRAEL , weighting 6.39 lb, was treated with Haloperidol (View Usage). After Haloperidol was administered, patient had the following side effects: emphysema, respiratory disorder. Haloperidol dosage: . During the same period patient was treated with PENFLURIDOL (View Penfluridol Review and Penfluridol Label ), CHLORPROTHIXEN (View Chlorprothixen Review and Chlorprothixen Label ).

6861582-3 | Cardio-respiratory Arrest, Respiratory Distress, Sinus Tachycardia
Patient was taking Haloperidol (View Usage). Patient experienced the following unwanted or unexpected effects: cardio-respiratory arrest, respiratory distress, sinus tachycardia on Jul 06, 2010 from TURKEY Additional patient health information: Male patient , 36 years of age, was diagnosed with acute psychosis, schizophrenia and. Haloperidol dosage: . During the same period patient was treated with CHLORPROMAZINE (View Chlorpromazine Review and Chlorpromazine Label ), OLANZAPINE (View Olanzapine Review and Olanzapine Label ), RISPERIDONE (View Risperidone Review and Risperidone Label ).

6861581-1 | Cardio-respiratory Arrest, Respiratory Distress, Sinus Tachycardia
Adverse event was reported on Jul 06, 2010 by a Male patient taking Haloperidol (View Usage) (Dosage: ) was diagnosed with acute psychosis, schizophrenia and. Location: TURKEY , 36 years of age, Patient had the following side effects: cardio-respiratory arrest, respiratory distress, sinus tachycardia. During the same period patient was treated with CHLORPROMAZINE (View Chlorpromazine Review and Chlorpromazine Label ), OLANZAPINE (View Olanzapine Review and Olanzapine Label ), RISPERIDONE (View Risperidone Review and Risperidone Label ).

6844446-0 | Delusion, Hallucination, Parkinsonism
on Jul 03, 2010 Female patient from MEXICO , 72 years of age, was treated with Haloperidol (View Usage). After Haloperidol was administered, patient had the following side effects: delusion, hallucination, parkinsonism. Haloperidol dosage: Per Night.

6840130-8 | Neuroleptic Malignant Syndrome, Pneumonia Aspiration
on Jul 04, 2010 Male patient from CANADA , 67 years of age, was diagnosed with delirium and was treated with Haloperidol (View Usage). Patient experienced the following unwanted or unexpected effects: neuroleptic malignant syndrome, pneumonia aspiration. Haloperidol dosage: 2.5-7.5mg (7 Days).

6840121-7 | Neuroleptic Malignant Syndrome
Patient was taking Haloperidol (View Usage). Patient had the following side effects: neuroleptic malignant syndrome on Jul 04, 2010 from CANADA Additional patient health information: Male patient , 81 years of age, was diagnosed with aggression, agitation, confusional state and. Haloperidol dosage: 9 Days. During the same period patient was treated with HALOPERIDOL DECANOATE (View Haloperidol Decanoate Review and Haloperidol Decanoate Label ).

6835610-5 | Hallucination, Auditory, Salivary Hypersecretion
Adverse event was reported on Jul 05, 2010 by a Male patient taking Haloperidol (View Usage) (Dosage: ) was diagnosed with hallucination, auditory and. Location: UNITED STATES , 22 years of age, After Haloperidol was administered, patient had the following side effects: hallucination, auditory, salivary hypersecretion. During the same period patient was treated with LITHIUM (View Lithium Review and Lithium Label ), RISPERIDONE (View Risperidone Review and Risperidone Label ).

6835296-X | Embolism Venous
on Jul 04, 2010 Male patient from BELGIUM , 37 years of age, was diagnosed with schizophrenia and was treated with Haloperidol (View Usage). Patient experienced the following unwanted or unexpected effects: embolism venous. Haloperidol dosage: . During the same period patient was treated with OLANZAPINE (View Olanzapine Review and Olanzapine Label ).

6831209-5 |
on Jul 02, 2010 Female patient from UNITED STATES , 64 years of age, was diagnosed with psychomotor hyperactivity and was treated with Haloperidol (View Usage). . Haloperidol dosage: . During the same period patient was treated with CARBAMAZEPINE (View Carbamazepine Review and Carbamazepine Label ), DIAZEPAM (View Diazepam Review and Diazepam Label ), OLANZAPINE (View Olanzapine Review and Olanzapine Label ), LEVOPROMAZINE (View Levopromazine Review and Levopromazine Label ).

6831189-2 | Deep Vein Thrombosis
Patient was taking Haloperidol (View Usage). After Haloperidol was administered, patient had the following side effects: deep vein thrombosis (What is deep vein thrombosis?) on Jul 04, 2010 from BELGIUM Additional patient health information: Female patient , 29 years of age, was diagnosed with schizophrenia, catatonic type and. Haloperidol dosage: .

6831188-0 | Embolism Venous
Adverse event was reported on Jul 04, 2010 by a Male patient taking Haloperidol (View Usage) (Dosage: ) was diagnosed with bipolar i disorder and. Location: BELGIUM , 59 years of age, Patient experienced the following unwanted or unexpected effects: embolism venous. During the same period patient was treated with CLONAZEPAM (View Clonazepam Review and Clonazepam Label ).

6831187-9 | Cardiac Failure, Hypotension
on Jul 02, 2010 Male patient from UNITED STATES , 34 years of age, was treated with Haloperidol (View Usage). Patient had the following side effects: cardiac failure, hypotension. Haloperidol dosage: . During the same period patient was treated with FENTANYL CITRATE (View Fentanyl Citrate Review and Fentanyl Citrate Label ), DIAZEPAM (View Diazepam Review and Diazepam Label ), HYDROCORTISONE (View Hydrocortisone Review and Hydrocortisone Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), HEPARIN (View Heparin Review and Heparin Label ), VECURONIUM BROMIDE (View Vecuronium Bromide Review and Vecuronium Bromide Label ), MIDAZOLAM HCL (View Midazolam Hcl Review and Midazolam Hcl Label ), FLUMAZENIL (View Flumazenil Review and Flumazenil Label ).

6831186-7 |
on Jul 07, 2010 Male patient from UNITED KINGDOM , 69 years of age, weighting 304.2 lb, was diagnosed with agitation, psychotic behaviour, depression (What is depression?), bipolar disorder (What is bipolar disorder?) and was treated with Haloperidol (View Usage). . Haloperidol dosage: . During the same period patient was treated with ARIPIPRAZOLE (View Aripiprazole Review and Aripiprazole Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), DIAZEPAM (View Diazepam Review and Diazepam Label ).

6831163-6 | Arteriosclerosis, Cardiac Disorder, Cardiomyopathy, Constipation, Cyanosis, Hypertension, Ischaemia, Pulmonary Embolism, Tachycardia
Patient was taking Haloperidol (View Usage). Patient experienced the following unwanted or unexpected effects: arteriosclerosis, cardiac disorder, cardiomyopathy (What is cardiomyopathy?), constipation (What is constipation?), cyanosis, hypertension, ischaemia, pulmonary embolism (What is pulmonary embolism?), tachycardia on Jul 02, 2010 from UNITED STATES Additional patient health information: Male patient , 59 years of age, was diagnosed with delirium, agitation and. Haloperidol dosage: . During the same period patient was treated with OLANZAPINE (1 Dose Of 10 Mg The First Day, 2 Doses Of 10 Mg On Second Day, 3 Doses Of 10 Mg On Third Day) (View Olanzapine Review and Olanzapine Label ), CHLORPROTHIXENE (View Chlorprothixene Review and Chlorprothixene Label ), CLOZAPINE (View Clozapine Review and Clozapine Label ), LEVOPROMAZINE (View Levopromazine Review and Levopromazine Label ), CORDIAMIN (View Cordiamin Review and Cordiamin Label ), TRIHEXYPHENIDYL HCL (View Trihexyphenidyl Hcl Review and Trihexyphenidyl Hcl Label ), TISERCIN (View Tisercin Review and Tisercin Label ).

6831161-2 | Pulmonary Embolism
Adverse event was reported on Jul 02, 2010 by a Male patient taking Haloperidol (View Usage) (Dosage: ) was diagnosed with agitation and. Location: UNITED STATES , 47 years of age, Patient had the following side effects: pulmonary embolism (What is pulmonary embolism?). During the same period patient was treated with OLANZAPINE (2 Doses Of 10mg 4hours Apart) (View Olanzapine Review and Olanzapine Label ), PROMAZINE HYDROCHLORIDE (View Promazine Hydrochloride Review and Promazine Hydrochloride Label ), BIPERIDEN HYDROCHLORIDE TAB (View Biperiden Hydrochloride Tab Review and Biperiden Hydrochloride Tab Label ), PROPRANOLOL (View Propranolol Review and Propranolol Label ), VALPROIC ACID (View Valproic Acid Review and Valproic Acid Label ).

6831146-6 | Cardiac Disorder, Cardiac Hypertrophy, Overdose
on Jul 02, 2010 Male patient from UNITED STATES , 39 years of age, was treated with Haloperidol (View Usage). After Haloperidol was administered, patient had the following side effects: cardiac disorder, cardiac hypertrophy, overdose. Haloperidol dosage: . During the same period patient was treated with RISPERIDONE (View Risperidone Review and Risperidone Label ), RISPERIDONE DECANOATE (View Risperidone Decanoate Review and Risperidone Decanoate Label ), VALPROATE SODIUM (View Valproate Sodium Review and Valproate Sodium Label ), CLONAZEPAM (2 Doses Of 6 Mg) (View Clonazepam Review and Clonazepam Label ), CLORAZEPATE DIPOTASSIUM (View Clorazepate Dipotassium Review and Clorazepate Dipotassium Label ), BIPERIDEN HYDROCHLORIDE TAB (View Biperiden Hydrochloride Tab Review and Biperiden Hydrochloride Tab Label ), OLANZAPINE (1 Dose Of 10 Mg Olanzepine On 4 Separate Days) (View Olanzapine Review and Olanzapine Label ), ZUCLOPENTHIXOL (View Zuclopenthixol Review and Zuclopenthixol Label ).

6831145-4 |
on Jul 02, 2010 Male patient from UNITED STATES , 61 years of age, was treated with Haloperidol (View Usage). . Haloperidol dosage: . During the same period patient was treated with RISPERIDONE (View Risperidone Review and Risperidone Label ), ZUCLOPENTHIXOL (View Zuclopenthixol Review and Zuclopenthixol Label ), DIAZEPAM (View Diazepam Review and Diazepam Label ), MIDAZOLAM HCL (View Midazolam Hcl Review and Midazolam Hcl Label ), OLANZAPINE (View Olanzapine Review and Olanzapine Label ).

6831144-2 | Depressed Level Of Consciousness, Drooling, Haemorrhagic Stroke, Head Injury, Motor Dysfunction, Muscular Weakness, Speech Disorder, Viith Nerve Paralysis
Patient was taking Haloperidol (View Usage). Patient had the following side effects: depressed level of consciousness, drooling, haemorrhagic stroke, head injury, motor dysfunction, muscular weakness, speech disorder, viith nerve paralysis on Jul 02, 2010 from UNITED STATES Additional patient health information: Female patient , 82 years of age, was diagnosed with aggression, agitation and. Haloperidol dosage: . During the same period patient was treated with LORAZEPAM (View Lorazepam Review and Lorazepam Label ), OLANZAPINE (View Olanzapine Review and Olanzapine Label ).